Characterization of Tigecycline-Heteroresistant Klebsiella pneumoniae Clinical Isolates From a Chinese Tertiary Care Teaching Hospital

Tigecycline has been used as one of the therapeutic choices for the treatment of infections caused by multidrug-resistant Klebsiella pneumoniae. However, the emergence of tigecycline heteroresistance has led to great challenges in treating these infections. The purpose of this study was to investiga...

Full description

Bibliographic Details
Main Authors: Qiaoyu Zhang, Liping Lin, Yuhong Pan, Jiansen Chen
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-08-01
Series:Frontiers in Microbiology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fmicb.2021.671153/full
_version_ 1818359210076798976
author Qiaoyu Zhang
Liping Lin
Yuhong Pan
Jiansen Chen
author_facet Qiaoyu Zhang
Liping Lin
Yuhong Pan
Jiansen Chen
author_sort Qiaoyu Zhang
collection DOAJ
description Tigecycline has been used as one of the therapeutic choices for the treatment of infections caused by multidrug-resistant Klebsiella pneumoniae. However, the emergence of tigecycline heteroresistance has led to great challenges in treating these infections. The purpose of this study was to investigate whether tigecycline-heteroresistant K. pneumoniae (TGCHR-Kp) exists in clinical isolates, and to further characterize the underlying molecular mechanisms involved in the development of tigecycline-resistant subpopulations. Of the 268 tigecycline-susceptible clinical K. pneumoniae isolates, 69 isolates were selected as tigecycline-heteroresistant candidates in the preliminary heteroresistant phenotypic selection by a modified disk diffusion method, and only 21 strains were confirmed as TGCHR-Kp by the population analysis profile (PAP). Pulsed-field gel electrophoresis (PFGE) analysis demonstrated that all the parental TGCHR-Kp isolates were clonally unrelated, and colonies confirmed as the heteroresistant subpopulation showed no significant differences from their respective parental TGCHR-Kp isolates. Efflux pump inhibitors reversed the tigecycline susceptibility in heteroresistant subpopulations. Mutations in the ramR and soxR genes lead to upregulation of the ramA and soxS transcriptional regulators, which in turn induced overexpression of the AcrAB-TolC efflux pump genes in TGCHR-Kps-resistant subpopulations. Moreover, mutations of rpsJ were also found in resistant subpopulations, which suggested that the rpsJ mutation may also lead to tigecycline resistance. Time-kill assays showed that the efficacy of tigecycline against TGCHR-Kps was weakened, whereas the number of resistant subpopulations was enriched by the presence of tigecycline. Our findings imply that the presence of TGCHR-Kps in clinical strains causes severe challenges for tigecycline therapy in clinical practice.
first_indexed 2024-12-13T20:41:16Z
format Article
id doaj.art-7f5ae55df87d494dbee3b11324d19bd2
institution Directory Open Access Journal
issn 1664-302X
language English
last_indexed 2024-12-13T20:41:16Z
publishDate 2021-08-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Microbiology
spelling doaj.art-7f5ae55df87d494dbee3b11324d19bd22022-12-21T23:32:08ZengFrontiers Media S.A.Frontiers in Microbiology1664-302X2021-08-011210.3389/fmicb.2021.671153671153Characterization of Tigecycline-Heteroresistant Klebsiella pneumoniae Clinical Isolates From a Chinese Tertiary Care Teaching HospitalQiaoyu Zhang0Liping Lin1Yuhong Pan2Jiansen Chen3Department of Nosocomial Infection Control, Fujian Medical University Union Hospital, Fuzhou, ChinaDepartment of Laboratory Medicine, School of Medical Technology and Engineering, Fujian Medical University, Fuzhou, ChinaDepartment of Clinical Laboratory, Fujian Medical University Union Hospital, Fuzhou, ChinaDepartment of Nosocomial Infection Control, Fujian Medical University Union Hospital, Fuzhou, ChinaTigecycline has been used as one of the therapeutic choices for the treatment of infections caused by multidrug-resistant Klebsiella pneumoniae. However, the emergence of tigecycline heteroresistance has led to great challenges in treating these infections. The purpose of this study was to investigate whether tigecycline-heteroresistant K. pneumoniae (TGCHR-Kp) exists in clinical isolates, and to further characterize the underlying molecular mechanisms involved in the development of tigecycline-resistant subpopulations. Of the 268 tigecycline-susceptible clinical K. pneumoniae isolates, 69 isolates were selected as tigecycline-heteroresistant candidates in the preliminary heteroresistant phenotypic selection by a modified disk diffusion method, and only 21 strains were confirmed as TGCHR-Kp by the population analysis profile (PAP). Pulsed-field gel electrophoresis (PFGE) analysis demonstrated that all the parental TGCHR-Kp isolates were clonally unrelated, and colonies confirmed as the heteroresistant subpopulation showed no significant differences from their respective parental TGCHR-Kp isolates. Efflux pump inhibitors reversed the tigecycline susceptibility in heteroresistant subpopulations. Mutations in the ramR and soxR genes lead to upregulation of the ramA and soxS transcriptional regulators, which in turn induced overexpression of the AcrAB-TolC efflux pump genes in TGCHR-Kps-resistant subpopulations. Moreover, mutations of rpsJ were also found in resistant subpopulations, which suggested that the rpsJ mutation may also lead to tigecycline resistance. Time-kill assays showed that the efficacy of tigecycline against TGCHR-Kps was weakened, whereas the number of resistant subpopulations was enriched by the presence of tigecycline. Our findings imply that the presence of TGCHR-Kps in clinical strains causes severe challenges for tigecycline therapy in clinical practice.https://www.frontiersin.org/articles/10.3389/fmicb.2021.671153/fullKlebsiella pneumoniaetigecyclineheteroresistanceefflux pumptime-killing assay
spellingShingle Qiaoyu Zhang
Liping Lin
Yuhong Pan
Jiansen Chen
Characterization of Tigecycline-Heteroresistant Klebsiella pneumoniae Clinical Isolates From a Chinese Tertiary Care Teaching Hospital
Frontiers in Microbiology
Klebsiella pneumoniae
tigecycline
heteroresistance
efflux pump
time-killing assay
title Characterization of Tigecycline-Heteroresistant Klebsiella pneumoniae Clinical Isolates From a Chinese Tertiary Care Teaching Hospital
title_full Characterization of Tigecycline-Heteroresistant Klebsiella pneumoniae Clinical Isolates From a Chinese Tertiary Care Teaching Hospital
title_fullStr Characterization of Tigecycline-Heteroresistant Klebsiella pneumoniae Clinical Isolates From a Chinese Tertiary Care Teaching Hospital
title_full_unstemmed Characterization of Tigecycline-Heteroresistant Klebsiella pneumoniae Clinical Isolates From a Chinese Tertiary Care Teaching Hospital
title_short Characterization of Tigecycline-Heteroresistant Klebsiella pneumoniae Clinical Isolates From a Chinese Tertiary Care Teaching Hospital
title_sort characterization of tigecycline heteroresistant klebsiella pneumoniae clinical isolates from a chinese tertiary care teaching hospital
topic Klebsiella pneumoniae
tigecycline
heteroresistance
efflux pump
time-killing assay
url https://www.frontiersin.org/articles/10.3389/fmicb.2021.671153/full
work_keys_str_mv AT qiaoyuzhang characterizationoftigecyclineheteroresistantklebsiellapneumoniaeclinicalisolatesfromachinesetertiarycareteachinghospital
AT lipinglin characterizationoftigecyclineheteroresistantklebsiellapneumoniaeclinicalisolatesfromachinesetertiarycareteachinghospital
AT yuhongpan characterizationoftigecyclineheteroresistantklebsiellapneumoniaeclinicalisolatesfromachinesetertiarycareteachinghospital
AT jiansenchen characterizationoftigecyclineheteroresistantklebsiellapneumoniaeclinicalisolatesfromachinesetertiarycareteachinghospital